First Trust Amex Biotech Index Fund (FBT): Price and Financial Metrics ETF
FBT Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $165.79 | 52-week high | $166.85 |
Prev. close | $164.85 | 52-week low | $130.27 |
Day low | $165.28 | Volume | 10,094 |
Day high | $166.85 | Avg. volume | 26,706 |
50-day MA | $154.96 | Dividend yield | N/A |
200-day MA | $149.76 |
FBT Stock Price Chart Interactive Chart >
First Trust Amex Biotech Index Fund (FBT) ETF Bio
The investment objective of the First Trust Amex Biotech Index Fund ETF seeks to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
FBT ETF Info
Issuer | First Trust Portfolios |
Expense Ratio | 0.55% |
Underlying Index | NYSE Arca Biotechnology Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 1.15B |
Net Asset Value (NAV) | $164.75 |
Options? | Yes |
Total Holdings | 32 |
FBT Top Holdings
Symbol | Company | % of Total |
CORT | Corcept Therapeutics Incorporated | 3.62% |
BGNE | BeiGene Ltd. (ADR) | 3.49% |
ALKS | Alkermes Plc | 3.47% |
EXAS | Exact Sciences Corporation | 3.43% |
GILD | Gilead Sciences Inc. | 3.42% |
UTHR | United Therapeutics Corporation | 3.42% |
RGEN | Repligen Corporation | 3.4% |
GMAB | Genmab A/S (ADR) | 3.39% |
CPRX | Catalyst Pharmaceuticals Inc. | 3.38% |
INCY | Incyte Corporation | 3.38% |
FBT Price Returns
1-mo | 6.59% |
3-mo | 15.41% |
6-mo | 9.98% |
1-year | 7.79% |
3-year | 1.59% |
5-year | 23.47% |
YTD | 4.89% |
2023 | 2.55% |
2022 | -4.83% |
2021 | -2.26% |
2020 | 12.96% |
2019 | 19.74% |